1 / 6

Self-Determination and Maintaining Tobacco Abstinence

Self-Determination and Maintaining Tobacco Abstinence. University of Rochester Geoffrey C. Williams M.D., Ph.D. Holly McGregor Ph.D. Edward L. Deci Ph.D. Richard M. Ryan Ph.D. Darryl Sharp Ph.D., R.N., N.P. Mike McDermott, Ph.D. Primary Objectives.

ruana
Download Presentation

Self-Determination and Maintaining Tobacco Abstinence

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Self-Determination and Maintaining Tobacco Abstinence • University of Rochester • Geoffrey C. Williams M.D., Ph.D. • Holly McGregor Ph.D. • Edward L. Deci Ph.D. • Richard M. Ryan Ph.D. • Darryl Sharp Ph.D., R.N., N.P. • Mike McDermott, Ph.D.

  2. Primary Objectives • To complete 32 month follow-up of intensive tobacco dependence intervention • In a new trial, determine if the intensive intervention will increase: • adherence to medications • autonomy support, autonomy, competence and if these will increase cessation maintenance • if harm reduction + intensive intervention increases abstinence over intensive intervention

  3. Baseline Autonomous Motivation 1-month Autonomous Motivation Medication Taking 1-month Autonomy Support 6-month Cessation 1-month Perceived Competence Baseline Perceived Competence Self-determination model for tobacco abstinence . . .

  4. Assessments • Questionnaires • Demographics, Cholesterol, Smoking Hx • Health Care Climate-Autonomy Support • Treatment Self Regulation-Autonomy • Perceived Competence • Adherence to medication- MEMS • Baseline, 6 & 12 wks, 6, 12, 18, 24 months

  5. Outcomes • Primary: 6-month prolonged abstinence • biochemically validated • 12, 18, and 24 months • Secondary: • 7-day point prevalence-validated • longest number of days not smoking • days since last cigarette • Intention to treat and as treated (SEM)

  6. Collaborative Activities • Establish a core set of mediator measures to be used at all sites. • Establish “global positioning” metrics across health outcomes. • Physical health, Mental health, Quality of life • Establish planned meta-analyses now. • Share recruitment, and retention ideas

More Related